Cisco (CSCO) Tanks on Revenue Plunge and Slashed Guidance

Jacob Harper |


Cisco Systems (CSCO) reported earnings after the bell on Nov. 13 and the Silicon Valley tech giant saw a sharp decline in revenues, especially in markets outside of the US, and the company’s shares plummeted in response.

CEO John Chambers did not mince words when discussing the earnings in a conference call with investors, saying “I’ve never seen this before.” However, Chambers declined to shoulder the blame. He instead blamed the current macroeconomic climate caused by government activities, saying it caused “the lack of confidence that people are seeing.”

The earnings miss, combined with the significant revenue underperformance sent investors scurrying. Two analytical firms – Wedbush and Deutsche Bank (DB) – downgraded the stock, and Goldman Sachs Group ($GS)  took Cisco off of their Conviction Buy list. An additional 12 brokerages cut their price target on the tech giant.

For their first fiscal quarter earnings report, Cisco reported a net gain of $2 billion, or $0.37 per share, versus the net gain of $2.1 billion, or $0.39 per share, from the same period a year ago. Revenue for the quarter was $12.08 billion, as compared to $11.9 billion from the same quarter the previous year. Analysts were expecting a net gain of $0.51 per share on revenues of $12.34 billion.

Following the report of the earnings and revenue shortfall, Cisco’s shares fell sharply. Cisco was down 11.94 percent in midday trading to hit $21.12 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
DB Deutsche Bank AG 19.13 -0.58 -2.94 4,844,717
CSCO Cisco Systems Inc. 34.32 0.28 0.82 21,137,311
GS The Goldman Sachs Group Inc. 247.35 -3.84 -1.53 3,565,388
MYHA My Healthy Access Inc 0.00 0.00 0.00 0

Comments

Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.